| 摘要 |
The combination is applied for the treatment of diabetes mellitus, especially for diabetes of type 2, and commendations related to diabetes mellitus, The combination comprises from 2 to 8 mg of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (compound I) or its tautomeric form, or its pharmaceutically acceptable derivative in its capacity of insulin sensitiser, and sulphonylurea.
|
